This observation is opposite to our data for pathogenic mutations throughout the catalytic core of LRRK2 (Berwick and Harvey, 2012), and a PD risk variant in the C-terminal WD40 domain (Figure 7). The gene discussed is LRRK2; the disease is Parkinson disease.